| Senior Manager, New Product Planning |
Montreal |
Canada |
International |
Innovative Medicines |
Market Access |
Out 21, 2024 |
| Senior Market Access Manager |
New South Wales (NSW) |
Australia |
International |
Innovative Medicines |
Market Access |
Set 30, 2024 |
| Senior Marketing Manager |
Shanghai (Shanghai) |
China |
International |
Innovative Medicines |
Marketing |
Maio 15, 2024 |
| Senior Medical Information Manager 2 |
Dublin (Novartis Corporate Center (NOCC)) |
Ireland |
Operations |
CTS |
Research & Development |
Abril 23, 2024 |
| Senior Molecular Imaging Expert (Senior Principal Scientist) |
Cambridge (USA) |
USA |
Biomedical Research |
Pharma Research |
Research & Development |
Maio 27, 2024 |
| Senior MR |
Haikou (Hainan Province) |
China |
International |
Innovative Medicines |
Sales |
Set 05, 2024 |
| Senior MR |
Xiamen (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Junho 23, 2024 |
| Senior MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Out 14, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Julho 30, 2024 |
| Senior MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Out 14, 2024 |
| Senior MR |
Xiamen (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Junho 23, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Julho 30, 2024 |
| Senior MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Out 14, 2024 |
| Senior MR |
Xiamen (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Junho 23, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Julho 30, 2024 |
| Senior MR |
Xiamen (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Junho 23, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Julho 30, 2024 |
| Senior MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Out 14, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Julho 30, 2024 |
| Senior MR |
Xiamen (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Junho 23, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Julho 30, 2024 |
| Senior MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Out 14, 2024 |
| Senior MR |
Xiamen (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Junho 23, 2024 |
| Senior MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Out 14, 2024 |
| Senior MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Out 14, 2024 |
| Senior MR |
Xiamen (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Junho 23, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Julho 30, 2024 |
| Senior MR |
Xiamen (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Junho 23, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Julho 30, 2024 |
| Senior MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Out 14, 2024 |
| Senior MR |
Xiamen (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Junho 23, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Julho 30, 2024 |
| Senior MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Out 14, 2024 |
| Senior MR |
Xiamen (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Junho 23, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Julho 30, 2024 |
| Senior MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Out 14, 2024 |
| Senior MR |
Beijing (Beijing) |
China |
International |
Innovative Medicines |
Sales |
Maio 20, 2024 |
| Senior MR |
Xiamen (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Junho 17, 2024 |
| Senior MR |
Xiamen (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Junho 23, 2024 |
| Senior MR |
Fuzhou (Fujian Province) |
China |
International |
Innovative Medicines |
Sales |
Julho 05, 2024 |
| Senior MR |
Wuhan (Hubei Province) |
China |
International |
Innovative Medicines |
Sales |
Julho 12, 2024 |
| Senior MR |
Guangzhou (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Julho 30, 2024 |
| Senior MR |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Out 14, 2024 |
| Senior Nuclear Medicine Radiologist |
Basel (City) |
Switzerland |
Biomedical Research |
Pharma Research |
Research & Development |
Set 20, 2024 |
| Senior Patient Access Lead |
Lithuania |
Lithuania |
International |
Innovative Medicines |
Market Access |
Out 14, 2024 |
| Senior Patient Safety Specialist |
Seoul |
South Korea |
Development |
Innovative Medicines |
Research & Development |
Out 20, 2024 |
| Senior Pharmareferent (m/w/d), Onkologie / Urologie / RLT, Gebiet: Rheinland-Pfalz & Saarland |
Saarland (Novartis Pharma GmbH) |
Germany |
International |
Innovative Medicines |
Sales |
Out 16, 2024 |
| Senior Platform Linux Engineer / DevOps |
Prague |
Czech Republic |
Operations |
CTS |
Technology Transformation |
Agosto 06, 2024 |
| Senior Principal Analyst - Data Operations |
Hyderabad (Office) |
India |
Biomedical Research |
Pharma Research |
Research & Development |
Set 03, 2024 |
| Senior Principal Biostatistician |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Research & Development |
Out 04, 2024 |